Bristol-Myers Squibb | BMY - Marktkapitalisierung

Aktienkurs
57.59
Täglich Wechseln
-0.67 -1.15%
Monatlich
-3.58%
Jährlich
14.72%
Q2 Prognose
57.45




Marktkapitalisierung Veränderung Datum
AbbVie USD 355.2B 48.64B 2026-04
Abbott USD 168.02B 10.39B 2026-04
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 210.86B 90.39B 2026-04
Biogen USD 27.49B 589M 2026-04
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 78.79B 5.01B 2026-04
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Novartis USD 231.75B 76B 2026-04
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Zoetis USD 55.45B 9.4B 2025-12